title: Recent progress in antitumoral synthetic vaccines.
abstract: Antitumoral synthetic vaccines offer a promising alternative to overcome problems associated with traditional treatments. Numerous vaccine prototypes have been described in the last two decades; however, none of them have been revealed satisfactory in clinical trials due to side effects, low bioavailability, uncertain molecular composition, and/or reproducibility. Here we highlight major advances in carbohydrate-based vaccines, which open new perspectives in cancer immunotherapy.
authors.affiliation: Department of Chemistry "Ugo Schiff″, University of Florence , via della Lastruccia 13, 50019 Sesto F. no, FI, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Nativi
authors.affiliation: Univ. Grenoble Alpes and CNRS , DCM, 38000 Grenoble, France ; Institut Universitaire de France , 103 Boulevard Saint-Michel, 75005 Paris, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Renaudet